Researchers identified three obesity subtypes in new research. In one subtype, individuals have low GLP-1 and rapid gastric ...

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive results from a Phase 2b trial evaluating the safety and efficacy of ...

The mandate approved today follows the adoption on 11 May 2026 of a regulation extending data protection periods regarding ...

EClinCloud, an AI technology company for clinical research that builds a unified clinical cloud platform and endpoint ...

Many healthcare professionals do not attribute symptoms such as fatigue, mood changes or sleep disruptions to menopause, leading to a missed opportunity for proper treatment in midlife women, ...